1582 related articles for article (PubMed ID: 25552356)
1. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
[TBL] [Abstract][Full Text] [Related]
2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
3. Letter by Campbell Regarding Article, "Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction".
Campbell DJ
Circulation; 2015 Oct; 132(16):e205. PubMed ID: 26481571
[No Abstract] [Full Text] [Related]
4. What the dead can teach the living: systemic nature of heart failure with preserved ejection fraction.
Kitzman DW; Upadhya B; Vasu S
Circulation; 2015 Feb; 131(6):522-4. PubMed ID: 25552355
[No Abstract] [Full Text] [Related]
5. Letter by Edwards et al Regarding Article, "Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction".
Edwards NC; Hayer MK; Ferro CJ
Circulation; 2015 Oct; 132(16):e204. PubMed ID: 26481570
[No Abstract] [Full Text] [Related]
6. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
[TBL] [Abstract][Full Text] [Related]
7. Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection Fraction.
Zakeri R; Moulay G; Chai Q; Ogut O; Hussain S; Takahama H; Lu T; Wang XL; Linke WA; Lee HC; Redfield MM
Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758811
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
Rush CJ; Berry C; Oldroyd KG; Rocchiccioli JP; Lindsay MM; Touyz RM; Murphy CL; Ford TJ; Sidik N; McEntegart MB; Lang NN; Jhund PS; Campbell RT; McMurray JJV; Petrie MC
JAMA Cardiol; 2021 Oct; 6(10):1130-1143. PubMed ID: 34160566
[TBL] [Abstract][Full Text] [Related]
9. [Pathological characteristics of the heart and coronary artery from elderly heart failure patients with preserved ejection fraction and coronary artery disease].
Chai K; Wang H; Li YY; Luo Y; Fang F; Liu DG; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Aug; 45(8):710-715. PubMed ID: 28851190
[No Abstract] [Full Text] [Related]
10. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M
Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425
[TBL] [Abstract][Full Text] [Related]
11. Implications of coronary artery disease in heart failure with preserved ejection fraction.
Hwang SJ; Melenovsky V; Borlaug BA
J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2817-27. PubMed ID: 24768876
[TBL] [Abstract][Full Text] [Related]
12. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
van Heerebeek L; Hamdani N; Falcão-Pires I; Leite-Moreira AF; Begieneman MP; Bronzwaer JG; van der Velden J; Stienen GJ; Laarman GJ; Somsen A; Verheugt FW; Niessen HW; Paulus WJ
Circulation; 2012 Aug; 126(7):830-9. PubMed ID: 22806632
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
Alex L; Russo I; Holoborodko V; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
[TBL] [Abstract][Full Text] [Related]
14. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction.
Paulus WJ; Dal Canto E
JACC Heart Fail; 2018 Jan; 6(1):1-7. PubMed ID: 29284577
[TBL] [Abstract][Full Text] [Related]
15. Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction.
Srivaratharajah K; Coutinho T; deKemp R; Liu P; Haddad H; Stadnick E; Davies RA; Chih S; Dwivedi G; Guo A; Wells GA; Bernick J; Beanlands R; Mielniczuk LM
Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413034
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and characteristics of coronary artery disease in heart failure with preserved and mid-range ejection fractions: A systematic angiography approach.
Trevisan L; Cautela J; Resseguier N; Laine M; Arques S; Pinto J; Orabona M; Barraud J; Peyrol M; Paganelli F; Bonello L; Thuny F
Arch Cardiovasc Dis; 2018 Feb; 111(2):109-118. PubMed ID: 29031580
[TBL] [Abstract][Full Text] [Related]
17. Response to Letters Regarding Article, "Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction".
Mohammed SF; Redfield MM
Circulation; 2015 Oct; 132(16):e206. PubMed ID: 26481572
[No Abstract] [Full Text] [Related]
18. Impaired myocardial oxygen availability contributes to abnormal exercise hemodynamics in heart failure with preserved ejection fraction.
van Empel VP; Mariani J; Borlaug BA; Kaye DM
J Am Heart Assoc; 2014 Dec; 3(6):e001293. PubMed ID: 25468660
[TBL] [Abstract][Full Text] [Related]
19. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction.
Melenovsky V; Borlaug BA; Rosen B; Hay I; Ferruci L; Morell CH; Lakatta EG; Najjar SS; Kass DA
J Am Coll Cardiol; 2007 Jan; 49(2):198-207. PubMed ID: 17222731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
